You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Ann-Victoria Isaac and I, Vasiliki Theologia Chioti, are going to work on the synthesis of 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidinediamine, which is traded as Daraprim. The reaction scheme we will follow is attached below. Use the following link to access our electronic lab notebook and monitor the progress of our research: http://malaria.ourexperiment.org/daraprim_malaria
ClC2=CC=C(C(C(N)=NC(N)=N3)=C3CC)C=C2
The text was updated successfully, but these errors were encountered:
You mean of the synthesis itself? Back story in #311 It's a project running in parallel to our pursuit of Series 4 (the molecules for which we need a predictive model). The targets and uses are not related.
Ann-Victoria Isaac and I, Vasiliki Theologia Chioti, are going to work on the synthesis of 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidinediamine, which is traded as Daraprim. The reaction scheme we will follow is attached below. Use the following link to access our electronic lab notebook and monitor the progress of our research: http://malaria.ourexperiment.org/daraprim_malaria
ClC2=CC=C(C(C(N)=NC(N)=N3)=C3CC)C=C2
The text was updated successfully, but these errors were encountered: